Project Optimus – FDA’s New Dose Optimization & Selection Paradigm in Oncology Drug Development
1:32:20
GastroPlus® Lecture Series Part II Mechanistic IVIVCs and Virtual BE trial simulations
55:19
How to Define & Measure Clinical Endpoints to Optimize Your Oncology Drug Dosing
1:28:43
Modeling and Simulation to Select Oncology Dosages - Session 1
58:28
HEALEY ALS Platform Trial Webinar: August 22, 2024 | Drug Development Discussion
28:23
FDA Product Regulations Part 1 of 7
3:40:21
Supporting the Use of RWD in Oncology Drug Development
1:02:33
Ocular Drug Discovery & Development: Driving and Optimizing Complex Formulations
1:03:56